News

BrightFocus researchers have reported that IL-18 can prevent the fragile, leaky blood vessels forming on the retina.

Yale School of Medicine Researchers have discovered a promising new drug compound that reverses some Alzheimer’s effects on memory in mice.

The FDA approves EYLEA, a new product for treatment of wet age-related macular degeneration (wet AMD).

The FDA announced in August 2011 that a decision regarding drug approval would be delayed until November 18.

1 … 60 61 62

Showing 367-371 of 371